SCHEMBL19397692

SCHEMBL19397692

CC(C)[C@@H](C)CN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL441083 1.00
SCHEMBL14626793 1.00
SCHEMBL18635881 0.79 PIK3CD (0.36)
SCHEMBL21566776 0.76
SCHEMBL21037937 0.76
SCHEMBL22259774 0.76 HTR2A (0.32)
SCHEMBL19542919 0.74
SCHEMBL19984376 0.74
SCHEMBL23902113 0.73
SCHEMBL22928603 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265092-A1 COMPOUNDS WHICH INHIBIT RNA POLYMERASE LIEBER INSTITUTE, INC. 2023-08-24 US disclosed
US-20230135560-A1 GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2023-05-04 US disclosed
US-11318134-B2 Benzamide compounds RECURIUM IP HOLDINGS, LLC (US) 2022-05-03 US disclosed
US-20200339605-A1 BENZAMIDE COMPOUNDS ZENO MANAGEMENT, INC. 2020-10-29 US disclosed
US-20180216108-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2018-08-02 US disclosed
US-20170275289-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-09-28 US disclosed